Teligent, Inc. TLGT Income Statement

Teligent, inc. (TLGT)

Income statement / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Components of Revenue:
Revenue, net
65,896	66,706	66,534	64,442	65,865	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue, net
-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	-	61,121	56,787	48,409	43,497	44,227	38,857	36,231	32,104	24,267	22,212	19,897	16,981	12,833	10,347	8,502	6,545	6,534	7,015	6,878	6,729	6,561	6,109	0	0	0
Research and development services and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	896	694	827	753	898	1,293	1,484	1,636	2,201	1,576	1,248	1,094	841	1,327	1,782	1,931	1,751	1,374	1,078	921	703	744	0	0	0
Licensing, royalty and other revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	262	269	249	149	0	0	0	-	-	-	-	-	-	-	-	-	-
Licensing, royalty and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Licensing, royalty and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	62,017	57,481	49,236	44,250	44,915	39,968	37,558	33,740	26,730	24,057	21,394	18,224	13,806	11,797	10,414	8,563	8,350	8,477	8,064	7,806	7,455	7,086	0	0	0
Costs and Expenses:
Cost of revenues
42,373	39,461	39,850	41,515	43,480	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenues
-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	30,548	27,949	25,594	22,935	21,153	19,651	18,004	16,948	15,750	14,398	13,491	12,079	9,448	7,986	6,996	5,787	5,704	5,961	5,671	5,546	5,399	5,482	0	0	0
Selling, general and administrative expenses
20,785	23,183	23,021	23,561	23,408	20,860	21,986	20,965	19,904	19,168	16,891	15,897	15,005	15,675	14,414	12,843	11,336	8,888	7,579	6,594	5,976	4,969	4,537	4,087	3,484	2,901	3,189	3,098	3,078	3,032	2,661	2,804	3,078	3,060	3,265	0	0	0
Product development and research expenses
10,758	11,352	12,375	13,674	14,076	16,323	17,842	18,988	19,265	18,031	17,442	17,097	17,140	16,348	15,584	14,252	13,171	11,184	9,583	8,175	6,910	5,664	4,673	3,450	2,743	3,223	3,182	3,021	2,834	2,313	2,135	2,243	2,151	1,946	1,872	0	0	0
Total costs and expenses
73,916	73,996	75,246	78,750	80,964	76,224	76,096	73,151	71,999	68,257	64,726	62,574	60,470	62,571	57,947	52,689	47,442	41,225	36,813	32,773	29,834	26,383	23,608	21,028	18,306	15,572	14,357	13,115	11,699	11,049	10,757	10,718	10,775	10,405	10,619	0	0	0
Operating loss
-8,020	-7,290	-8,712	-14,308	-15,099	-14,597	-21,423	-18,295	-11,797	-6,528	1,814	4,672	2,542	-554	-466	-3,453	-3,192	3,690	3,155	4,785	3,906	347	449	366	-82	-1,766	-2,560	-2,701	-3,136	-2,699	-2,280	-2,654	-2,969	-2,950	-3,533	0	0	0
Other Expense:
Change in the fair value of derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23,144	25,444	25,444	10,925	2,300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency exchange loss
-1,523	-3,758	-1,767	-5,540	-3,371	-997	923	7,965	7,719	4,414	3,034	-1,410	-936	1,404	1,040	1,662	109	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt extinguishment of Prior Term Loan
0	-967	-967	1,500	1,315	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other expense, net
-21,154	-19,796	-17,329	-14,673	-12,298	-10,231	-10,201	-10,638	-11,198	-12,038	-12,722	-13,118	-13,304	-13,676	-13,608	-13,508	-13,358	-10,299	-7,078	-3,898	-782	-215	0	0	-	0	-	-	-975	-828	-312	-297	-281	0	0	0	0	0
Loss before income tax expense
-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense / (benefit)
91	73	-22	-72	-62	-275	-151	-148	-85	349	348	348	287	103	80	57	35	161	161	173	173	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred stock dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Interest expense and other, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common shareholders
-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	291	398	340	-84	-1,937	-3,264	-3,449	-3,927	-3,284	-2,349	-2,708	-3,007	-3,147	-3,659	0	0	0
Basic and diluted loss per share (in dollars per share)
-0.10	-0.13	-0.08	-0.16	-0.27	-0.07	-0.25	-0.09	-0.11	-0.17	-0.02	0.02	-0.11	-0.05	-0.05	-0.02	-	-	-	-	-	-	-	-	-	0.00	-0.01	-	-	-0.04	-0.01	-0.02	-0.02	-0.01	-0.02	-0.03	-0.08	-0.06
Basic (loss) earnings per share (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.12	-0.05	0.18	0.12	0.12	0.00	-0.01	0.00	-	-	-	-0.01	-	-	-	-	-	-	-	-	-	-
Diluted (loss) earnings per share (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-0.05	-0.03	0.01	0.10	0.00	-0.01	0.00	-	-	-	-0.01	-	-	-	-	-	-	-	-	-	-
Weighted average shares of common stock outstanding:
Basic and diluted (in shares)
53,851	53,850	53,849	53,805	53,776	53,625	53,510	53,458	53,403	53,391	53,304	53,195	53,128	53,093	53,059	53,031	-	-	-	-	-	-	-	-	-	43,395	43,206	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52,918	52,869	52,861	52,841	52,879	52,457	47,107	46,826	-	-	-	42,933,146	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	81,242	52,869	67,125	67,210	108,734	52,457	47,107	48,529	-	-	-	42,933,146	40,614	39,508	39,522	39,500	39,500	39,498	39,482	39,313	24,876	17,706